Skip to content
Catalyst

PapersPMID:34178867

The effect of spirulina on type 2 diabetes: a systematic review and meta-analysis.

Journal of diabetes and metabolic disorders2021The record ↗

findings
3
compound
1
endpoints
3
no difference found
1
PMID:34178867
  1. Finding, very limited evidencelowersFasting blood glucose
  2. Finding, very limited evidencelowersTriglycerides
  3. Finding, very limited evidenceno difference foundGlycated haemoglobin (HbA1c)
Study, every finding
meta-analysis
Population, every finding
Patients with type 2 diabetes; eight studies (9 arms) pooled, random effects
  • “We found a significant reduction in fasting blood glucose (-17.88 mg/dl; 95% CI: -26.99, -8.78; I 2 : 25%), triglyceride (-30.99 mg/dl; 95% CI: -45.20, -16.77; I 2 : 50%), total-cholesterol (-18.47 mg/dl; 95% CI: -33.54, -3.39; I 2 : 73%), LDL-C (-20.04 mg/dl; 95% CI: -34.06, -6.02; I 2 : 75%), VLDL (-6.96 mg/dl; 95% CI: -9.71, -4.22; I 2 : 33%), in addition to a significant increase in HDL-C (-6.96 mg/dl; 95% CI: -9.71, -4.22; I 2 : 33%), after spirulina administration.”

What did not

Study record

Design
meta-analysis
Species
human
Population
Type 2 diabetes patients
Participants
not reported
Comparator
not stated in the paper
Duration
not reported
Endpoints measured
8